[go: up one dir, main page]

HN2002000162A - Vacuna de mycoplasma bovis y metodos para reducir la neumonia en animales - Google Patents

Vacuna de mycoplasma bovis y metodos para reducir la neumonia en animales

Info

Publication number
HN2002000162A
HN2002000162A HN2002000162A HN2002000162A HN2002000162A HN 2002000162 A HN2002000162 A HN 2002000162A HN 2002000162 A HN2002000162 A HN 2002000162A HN 2002000162 A HN2002000162 A HN 2002000162A HN 2002000162 A HN2002000162 A HN 2002000162A
Authority
HN
Honduras
Prior art keywords
methods
mycoplasma bovis
animals
bovis vaccine
pneumonia
Prior art date
Application number
HN2002000162A
Other languages
English (en)
Inventor
Lee Keich Robin
Ross Mcgavin David
John Yancey Robert
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HN2002000162A publication Critical patent/HN2002000162A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A UNA VACUNA DE MYCOPLASMA BOVIS Y ALOS METODOS PARA TRATAR O PREVENIR ENFERMEDADES O DESORDENES EN ANIMALES CAUSADOS POR INFECCIONES POR MYCOPLASMA BOVIS
HN2002000162A 2001-07-02 2002-06-28 Vacuna de mycoplasma bovis y metodos para reducir la neumonia en animales HN2002000162A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30263801P 2001-07-02 2001-07-02

Publications (1)

Publication Number Publication Date
HN2002000162A true HN2002000162A (es) 2002-09-17

Family

ID=23168600

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2002000162A HN2002000162A (es) 2001-07-02 2002-06-28 Vacuna de mycoplasma bovis y metodos para reducir la neumonia en animales

Country Status (31)

Country Link
US (1) US20030147914A1 (es)
EP (1) EP1401488A1 (es)
JP (1) JP2004536106A (es)
KR (1) KR20040030783A (es)
CN (1) CN1522152A (es)
AP (1) AP2002002568A0 (es)
AR (1) AR036125A1 (es)
BG (1) BG108496A (es)
BR (1) BR0210798A (es)
CA (1) CA2452580A1 (es)
CZ (1) CZ20033465A3 (es)
EA (1) EA200301324A1 (es)
GT (1) GT200200139A (es)
HN (1) HN2002000162A (es)
HR (1) HRP20031078A2 (es)
HU (1) HUP0501188A2 (es)
IL (1) IL159516A0 (es)
IS (1) IS7078A (es)
MA (1) MA27048A1 (es)
MX (1) MXPA03011815A (es)
NO (1) NO20035767L (es)
OA (1) OA12640A (es)
PA (1) PA8549801A1 (es)
PE (1) PE20030239A1 (es)
PL (1) PL373891A1 (es)
SK (1) SK15802003A3 (es)
TN (1) TNSN03154A1 (es)
UY (1) UY27365A1 (es)
WO (1) WO2003004052A1 (es)
YU (1) YU102103A (es)
ZA (1) ZA200309747B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179473B2 (en) 1998-06-05 2007-02-20 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
US7135561B2 (en) 2001-09-06 2006-11-14 Boehringer Ingelheim Vetmedica Gmbh Infectious bovine viral diarrhea virus clone
US7279166B2 (en) * 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
SE0301436D0 (sv) * 2003-05-16 2003-05-16 Joakim Westberg New proteins
US7572455B2 (en) * 2004-05-19 2009-08-11 Boehringer Ingelheim Vetmedica Gmbh Vaccine comprising an attenuated pestivirus
UY29915A1 (es) * 2005-11-15 2007-06-29 Boehringer Ingelheim Vetmed Vacuna combinada que comprende un virus atenuado de la diarrea viral bovina
US20110059437A1 (en) * 2006-09-07 2011-03-10 Boehringer Ingelheim Vetmedica, Inc. Pcr-based genotyping
JP5550341B2 (ja) 2006-09-11 2014-07-16 ゾエティス・ピー・エルエルシー 熱処理バクテリンおよびそのような熱処理バクテリンから調製された乳剤ワクチン
CL2008003202A1 (es) * 2007-10-29 2009-11-27 Boehringer Ingelheim Vetmedica Inc Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta.
UY31930A (es) * 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
CA2729080C (en) * 2008-07-03 2018-09-11 Ricardo Rosenbusch Cattle vaccines
WO2010051210A1 (en) * 2008-10-31 2010-05-06 Boehringer Ingelheim Vetmedica, Inc. Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
US8846054B2 (en) * 2009-01-09 2014-09-30 Boehringer Ingelheim Vetmedica, Inc. Method of treating pregnant cows and/or heifers
UY32570A (es) * 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
JP5968622B2 (ja) 2009-06-04 2016-08-10 国立感染症研究所長 マイコプラズマ感染症用ワクチン
CN102220263B (zh) * 2011-05-06 2012-10-03 华中农业大学 一种牛支原体致弱菌株及其应用
SG11201505089YA (en) 2012-12-28 2015-07-30 Boehringer Ingelheim Vetmed Method of making a mycoplasma vaccine
CN104857509A (zh) * 2015-06-02 2015-08-26 福清市默克兽医院 牛支原体肺炎组织灭活疫苗的制备方法、配方及使用方法
BR112018002919B1 (pt) 2015-08-14 2024-02-27 Zoetis Services Llc Composição imunogênica eficaz compreendendo uma cepa de mycoplasma bovis e usos da mesma para prevenção de doenças causadas por mycoplasma bovis
CN105441368B (zh) * 2016-01-19 2019-01-01 福清市默克兽医院 一株牛支原体及其应用
CN106929452B (zh) * 2017-04-11 2020-06-12 河南省农业科学院畜牧兽医研究所 一株牛支原体及其应用
CN109022314B (zh) * 2018-08-06 2021-08-13 北京华夏兴洋生物科技有限公司 一株牛支原体及其在疫苗研制中的应用
CN110338138B (zh) * 2019-06-19 2021-04-06 山东省农业科学院奶牛研究中心 一种牛支原体感染豚鼠的动物模型构建方法及其应用
CN112301041B (zh) * 2020-10-09 2022-05-24 华中农业大学 牛支原体p21蛋白及其应用
CN113546162B (zh) * 2021-05-31 2023-07-18 江苏省农业科学院 一种支原体疫苗及其制备方法
CN113604492B (zh) * 2021-09-10 2023-07-07 苏州世诺生物技术有限公司 融合基因、融合蛋白及制备方法和牛支原体亚单位疫苗

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
EP1229929A2 (en) * 1999-11-08 2002-08-14 Biomune VACCINES FOR i MYCOPLASMA BOVIS /i AND METHODS OF USE
DE29921392U1 (de) * 1999-12-06 2000-03-16 Dr. Felgenträger & Co. Öko-Chem. und Pharma GmbH, 06862 Rodleben Mykoplasma-bovis-Kombinations-Vakzine für Rinder
US6548069B2 (en) * 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin

Also Published As

Publication number Publication date
MA27048A1 (fr) 2004-12-20
US20030147914A1 (en) 2003-08-07
BG108496A (en) 2005-02-28
WO2003004052A1 (en) 2003-01-16
TNSN03154A1 (fr) 2005-12-23
IL159516A0 (en) 2004-06-01
SK15802003A3 (sk) 2005-01-03
GT200200139A (es) 2003-02-13
IS7078A (is) 2003-12-15
JP2004536106A (ja) 2004-12-02
NO20035767L (no) 2004-01-30
AP2002002568A0 (en) 2002-06-30
KR20040030783A (ko) 2004-04-09
UY27365A1 (es) 2003-04-30
HUP0501188A2 (en) 2006-05-29
AR036125A1 (es) 2004-08-11
HRP20031078A2 (en) 2005-08-31
EA200301324A1 (ru) 2004-12-30
ZA200309747B (en) 2005-05-27
CN1522152A (zh) 2004-08-18
CA2452580A1 (en) 2003-01-16
YU102103A (sh) 2006-05-25
CZ20033465A3 (cs) 2004-12-15
PA8549801A1 (es) 2003-09-17
MXPA03011815A (es) 2004-04-02
EP1401488A1 (en) 2004-03-31
BR0210798A (pt) 2006-05-23
PL373891A1 (en) 2005-09-19
OA12640A (en) 2006-06-15
PE20030239A1 (es) 2003-03-21

Similar Documents

Publication Publication Date Title
HN2002000162A (es) Vacuna de mycoplasma bovis y metodos para reducir la neumonia en animales
BRPI0506305A (pt) artigos e métodos de tratamento da pele
EP1812068A4 (en) METHOD FOR THE PREVENTION AND TREATMENT OF RSV INFECTIONS AND RELATED ACCIDENTS
BRPI0411900A (pt) compostos antivirais e métodos
TNSN07150A1 (en) Semi-soft c-class immunostimulatory oligonucleotides
CR9558A (es) Formulaciones de quinina
CL2011000877A1 (es) Composicion inmunogena para el tratamiento y/o profilaxis de ganado contra infecciones microbiologicas porque comprende antigeno de mycoplasma bovis; metodo de coadministracion de dos o mas antigenos a un ganado bovino.
BRPI0512841A (pt) composições e métodos para o tratamento de infecções patológicas
ECSP044985A (es) Azitromicina de dosis única para infecciones respiratorias
DK1675603T3 (da) Anvendelse af probiotiske bakterier i behandling af infektion
CY1109666T1 (el) Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας
AR036355A1 (es) Modelo de exposicion a mycoplasma bovis, para evaluar la eficacia de potenciales vacunas
BR0210632A (pt) Tratamento de doença parasìtica
EP1968566A4 (en) COMPOSITIONS OF CIS-9, TRANS-11 CONJUGATED LINOLIC ACID AND VACCENIC ACID AND ITS USES
ATE364389T1 (de) Verfahren zur herstellung von extrakten aus pelargonium sidoides und/oder pelargonium reniforme
PT1282599E (pt) Derivados dissulfureto uteis para tratar doencas alergicas
ATE359815T1 (de) Streptococcus-phocae-vakzine
ATE455789T1 (de) Substituierte nonadepsipeptide
GT200000114A (es) Forma cristalina iii de la n-(4-(5-dimetilaminoftalen-1-sulfonilamino) fenil)-3-hidroxi-2, 2-dimetilpropionamida.
DK1740206T3 (da) PHEP, en aminosyrepermease af Staphylococcus Aureus
BR0107442A (pt) Utilização da enoxaparina
EA200401523A1 (ru) Способы применения и композиции для диагностики и лечения инфекционного заболевания
DE60238554D1 (de) Vakzine gegen infektionskrankheiten
CL2006002620A1 (es) Composicion para la prevencion y tratamiento de infecciones causadas por coccidia en animales que consiste en yema con inmunoglobulas anti-eimeria, agua y un conservador; y metodo para la prevencion de infecciones causadas por parasitos coccidia que comprende la administracion oral de una o mas inmunoglobulinas anti eimeria.
ES1050463Y (es) Dispositivo terapeutico para el tratamiento de sintomas ocasionados por enfermedades.